Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Knowing what, exactly, is needed in cardiac PET documentation is one of the best ways to limit prior authorization issues.

Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.

Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.

"A significant part of burnout stems from the overwhelming administrative burden," explains Elizabeth Ann Ignacio, MD, FSIR, FACR, chair of the SIR Small and Rural Practices Committee.

Dana Smetherman, MD, CEO of the American College of Radiology, explains resources available through its Data Science Institute to evaluate and validate the quality of imaging algorithms.